Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 MAD Study of Lemborexant in Healthy Japanese and White Subjects
NCT02039089Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lemborexant in Insomnia (3 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Pharmacokinetic profiles of E2006 up to 49 days, Pharmacodynamic profile of E2006 up to 49 days and 5 more. Started Jan 2014; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02039089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039089.